

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 9.99879243 |
| 2 | regulation of dopamine secretion (GO:0014059) | 8.79501285 |
| 3 | determination of adult lifespan (GO:0008340) | 8.59099263 |
| 4 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 7.34472801 |
| 5 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 7.10095903 |
| 6 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 6.67735553 |
| 7 | alkaloid metabolic process (GO:0009820) | 6.64019087 |
| 8 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 6.37529337 |
| 9 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 6.21345360 |
| 10 | cullin deneddylation (GO:0010388) | 6.19558722 |
| 11 | neuron remodeling (GO:0016322) | 5.89189492 |
| 12 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 5.57926360 |
| 13 | chaperone-mediated protein complex assembly (GO:0051131) | 5.52268182 |
| 14 | protein import into peroxisome matrix (GO:0016558) | 5.44670721 |
| 15 | protein deneddylation (GO:0000338) | 5.34816583 |
| 16 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 4.97237677 |
| 17 | cAMP-mediated signaling (GO:0019933) | 4.82630275 |
| 18 | regulation of actin nucleation (GO:0051125) | 4.72852921 |
| 19 | phosphatidic acid metabolic process (GO:0046473) | 4.68041458 |
| 20 | phosphatidic acid biosynthetic process (GO:0006654) | 4.68041458 |
| 21 | dopamine transport (GO:0015872) | 4.67116076 |
| 22 | mating behavior (GO:0007617) | 4.51235839 |
| 23 | regulation of catecholamine secretion (GO:0050433) | 4.42456045 |
| 24 | positive regulation of microtubule polymerization (GO:0031116) | 4.40744826 |
| 25 | peristalsis (GO:0030432) | 4.36419536 |
| 26 | dopamine biosynthetic process (GO:0042416) | 4.29735265 |
| 27 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 4.18087019 |
| 28 | activation of adenylate cyclase activity (GO:0007190) | 4.11935693 |
| 29 | phosphatidylserine metabolic process (GO:0006658) | 4.06815426 |
| 30 | microtubule depolymerization (GO:0007019) | 4.04224340 |
| 31 | tyrosine metabolic process (GO:0006570) | 4.03978666 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.93609509 |
| 33 | phenol-containing compound catabolic process (GO:0019336) | 3.88844469 |
| 34 | toxin metabolic process (GO:0009404) | 3.84710497 |
| 35 | regulation of microtubule polymerization (GO:0031113) | 3.84657411 |
| 36 | adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189) | 3.78816674 |
| 37 | retinal cone cell development (GO:0046549) | 3.78141145 |
| 38 | bile acid and bile salt transport (GO:0015721) | 3.74976901 |
| 39 | response to redox state (GO:0051775) | 3.74901546 |
| 40 | termination of signal transduction (GO:0023021) | 3.71970376 |
| 41 | positive regulation of multicellular organism growth (GO:0040018) | 3.62135199 |
| 42 | negative regulation of microtubule polymerization (GO:0031115) | 3.61458542 |
| 43 | synaptic transmission, dopaminergic (GO:0001963) | 3.61191609 |
| 44 | phosphatidylglycerol metabolic process (GO:0046471) | 3.57818414 |
| 45 | positive regulation of adenylate cyclase activity (GO:0045762) | 3.57383367 |
| 46 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 3.54239211 |
| 47 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.51433363 |
| 48 | cyclic-nucleotide-mediated signaling (GO:0019935) | 3.49861062 |
| 49 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.49751513 |
| 50 | nonmotile primary cilium assembly (GO:0035058) | 3.43607736 |
| 51 | sulfation (GO:0051923) | 3.41642884 |
| 52 | behavioral response to nicotine (GO:0035095) | 3.40808665 |
| 53 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.33144155 |
| 54 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.33144155 |
| 55 | NADH dehydrogenase complex assembly (GO:0010257) | 3.33144155 |
| 56 | microtubule polymerization or depolymerization (GO:0031109) | 3.28660816 |
| 57 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.26165682 |
| 58 | protein complex biogenesis (GO:0070271) | 3.25815225 |
| 59 | succinate metabolic process (GO:0006105) | 3.23405455 |
| 60 | male meiosis (GO:0007140) | 3.20360983 |
| 61 | protein localization to peroxisome (GO:0072662) | 3.12872407 |
| 62 | protein targeting to peroxisome (GO:0006625) | 3.12872407 |
| 63 | establishment of protein localization to peroxisome (GO:0072663) | 3.12872407 |
| 64 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.09381225 |
| 65 | drug catabolic process (GO:0042737) | 3.08380809 |
| 66 | regulation of amine transport (GO:0051952) | 3.06357978 |
| 67 | dopamine metabolic process (GO:0042417) | 3.03450166 |
| 68 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 3.03435501 |
| 69 | alditol phosphate metabolic process (GO:0052646) | 2.98909463 |
| 70 | regulation of catecholamine metabolic process (GO:0042069) | 2.97762746 |
| 71 | regulation of dopamine metabolic process (GO:0042053) | 2.97762746 |
| 72 | mitotic cell cycle arrest (GO:0071850) | 2.95834711 |
| 73 | somite rostral/caudal axis specification (GO:0032525) | 2.95731106 |
| 74 | urinary tract smooth muscle contraction (GO:0014848) | 2.94987765 |
| 75 | lipopolysaccharide metabolic process (GO:0008653) | 2.92428558 |
| 76 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.89173412 |
| 77 | positive regulation of cyclase activity (GO:0031281) | 2.89072913 |
| 78 | catechol-containing compound biosynthetic process (GO:0009713) | 2.85873743 |
| 79 | catecholamine biosynthetic process (GO:0042423) | 2.85873743 |
| 80 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.85617231 |
| 81 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.85617231 |
| 82 | neurotransmitter biosynthetic process (GO:0042136) | 2.84745892 |
| 83 | negative regulation of cell aging (GO:0090344) | 2.84532245 |
| 84 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.84381603 |
| 85 | cellular response to nicotine (GO:0071316) | 2.84006030 |
| 86 | response to insecticide (GO:0017085) | 2.81469421 |
| 87 | basic amino acid transport (GO:0015802) | 2.80038592 |
| 88 | peroxisomal transport (GO:0043574) | 2.79797341 |
| 89 | positive regulation of cAMP biosynthetic process (GO:0030819) | 2.78050933 |
| 90 | 2-oxoglutarate metabolic process (GO:0006103) | 2.76641695 |
| 91 | cardiovascular system development (GO:0072358) | 2.75810401 |
| 92 | neuronal action potential (GO:0019228) | 2.75529714 |
| 93 | glomerular visceral epithelial cell development (GO:0072015) | 2.71289306 |
| 94 | fatty acid elongation (GO:0030497) | 2.69975767 |
| 95 | negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744) | 2.69552844 |
| 96 | positive regulation of lyase activity (GO:0051349) | 2.68609292 |
| 97 | cAMP catabolic process (GO:0006198) | 2.68589867 |
| 98 | positive regulation of growth hormone secretion (GO:0060124) | 13.7129987 |
| 99 | growth hormone secretion (GO:0030252) | 11.9745692 |
| 100 | regulation of growth hormone secretion (GO:0060123) | 10.0122232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 6.48534020 |
| 2 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 6.38935443 |
| 3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.20001050 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 4.02937765 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.96121269 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.89211506 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.37774102 |
| 8 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.26844388 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.94599552 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.84463667 |
| 11 | TP53_16413492_ChIP-PET_HCT116_Human | 2.83540372 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.69552875 |
| 13 | TP53_22573176_ChIP-Seq_HFKS_Human | 2.19406716 |
| 14 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.01237004 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.95496892 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.77122581 |
| 17 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.65730998 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.57619528 |
| 19 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.57614639 |
| 20 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57544322 |
| 21 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.54831085 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.54695058 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52530081 |
| 24 | * MYC_19829295_ChIP-Seq_ESCs_Human | 1.47351553 |
| 25 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42143426 |
| 26 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37825412 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.33293854 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.32743420 |
| 29 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.32448269 |
| 30 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.30775051 |
| 31 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30384185 |
| 32 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.28253310 |
| 33 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.26481056 |
| 34 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25491665 |
| 35 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25275653 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22511993 |
| 37 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22329591 |
| 38 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22329591 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.21839649 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.19836313 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18678842 |
| 42 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.18267110 |
| 43 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.17840110 |
| 44 | RXR_22108803_ChIP-Seq_LS180_Human | 1.17413542 |
| 45 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15637014 |
| 46 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.13786737 |
| 47 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.13761211 |
| 48 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.13536405 |
| 49 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.13381392 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.13066279 |
| 51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11539063 |
| 52 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.10305185 |
| 53 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.09280366 |
| 54 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.07453027 |
| 55 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.06691158 |
| 56 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06098941 |
| 57 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05494733 |
| 58 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.04889676 |
| 59 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.04646491 |
| 60 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04354109 |
| 61 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03185603 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.03112712 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.03112712 |
| 64 | ERA_21632823_ChIP-Seq_H3396_Human | 1.02529555 |
| 65 | TCF4_23295773_ChIP-Seq_U87_Human | 0.99973334 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99403587 |
| 67 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99129284 |
| 68 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.99068714 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98703695 |
| 70 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98555797 |
| 71 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98246318 |
| 72 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.97983202 |
| 73 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.97719736 |
| 74 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97719736 |
| 75 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97519035 |
| 76 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96566413 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.95864805 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94776748 |
| 79 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.93199474 |
| 80 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93185572 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.92272427 |
| 82 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91735948 |
| 83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90199671 |
| 84 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.89857094 |
| 85 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.89726999 |
| 86 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89187680 |
| 87 | * OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88889393 |
| 88 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.88448767 |
| 89 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88096437 |
| 90 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87948317 |
| 91 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87879686 |
| 92 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86855917 |
| 93 | AR_25329375_ChIP-Seq_VCAP_Human | 0.86673834 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.86467978 |
| 95 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85895824 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.84507122 |
| 97 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.83217467 |
| 98 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82670833 |
| 99 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82556374 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.81474533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001501_abnormal_sleep_pattern | 6.66132434 |
| 2 | MP0002653_abnormal_ependyma_morphology | 5.31969560 |
| 3 | MP0002102_abnormal_ear_morphology | 4.65623527 |
| 4 | MP0005551_abnormal_eye_electrophysiolog | 4.19642201 |
| 5 | MP0000569_abnormal_digit_pigmentation | 4.07922281 |
| 6 | MP0003950_abnormal_plasma_membrane | 3.47390659 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.03277120 |
| 8 | MP0001529_abnormal_vocalization | 3.00868079 |
| 9 | MP0003283_abnormal_digestive_organ | 2.90101815 |
| 10 | MP0001881_abnormal_mammary_gland | 2.72004375 |
| 11 | MP0000566_synostosis | 2.58307495 |
| 12 | MP0003959_abnormal_lean_body | 2.51044117 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.19960987 |
| 14 | MP0000631_abnormal_neuroendocrine_gland | 2.11932058 |
| 15 | MP0004924_abnormal_behavior | 1.95633599 |
| 16 | MP0005386_behavior/neurological_phenoty | 1.95633599 |
| 17 | MP0005365_abnormal_bile_salt | 1.85129913 |
| 18 | MP0005266_abnormal_metabolism | 1.71373551 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 1.63881322 |
| 20 | MP0004381_abnormal_hair_follicle | 1.59770204 |
| 21 | MP0001905_abnormal_dopamine_level | 1.52904187 |
| 22 | MP0009046_muscle_twitch | 1.48258509 |
| 23 | MP0002272_abnormal_nervous_system | 1.44761320 |
| 24 | MP0000026_abnormal_inner_ear | 1.38940376 |
| 25 | MP0001485_abnormal_pinna_reflex | 1.35301332 |
| 26 | MP0001968_abnormal_touch/_nociception | 1.34598793 |
| 27 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34051974 |
| 28 | MP0001986_abnormal_taste_sensitivity | 1.30788843 |
| 29 | MP0000383_abnormal_hair_follicle | 1.30015949 |
| 30 | MP0010386_abnormal_urinary_bladder | 1.25434234 |
| 31 | MP0002572_abnormal_emotion/affect_behav | 1.24607106 |
| 32 | MP0006035_abnormal_mitochondrial_morpho | 1.23855481 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.22971245 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.19434693 |
| 35 | MP0001177_atelectasis | 1.16282853 |
| 36 | MP0005394_taste/olfaction_phenotype | 1.15460541 |
| 37 | MP0005499_abnormal_olfactory_system | 1.15460541 |
| 38 | MP0005195_abnormal_posterior_eye | 1.14812887 |
| 39 | MP0001963_abnormal_hearing_physiology | 1.14463125 |
| 40 | MP0000579_abnormal_nail_morphology | 1.12529822 |
| 41 | MP0005253_abnormal_eye_physiology | 1.11171966 |
| 42 | MP0005164_abnormal_response_to | 1.10334139 |
| 43 | MP0003136_yellow_coat_color | 1.09843296 |
| 44 | MP0002229_neurodegeneration | 1.09726418 |
| 45 | MP0002736_abnormal_nociception_after | 1.07621611 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 1.07606428 |
| 47 | MP0008872_abnormal_physiological_respon | 1.05989011 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.04905545 |
| 49 | MP0004043_abnormal_pH_regulation | 1.04751233 |
| 50 | MP0005376_homeostasis/metabolism_phenot | 1.02590644 |
| 51 | MP0005171_absent_coat_pigmentation | 1.02387120 |
| 52 | MP0003195_calcinosis | 1.01795247 |
| 53 | MP0004142_abnormal_muscle_tone | 1.01008395 |
| 54 | MP0003937_abnormal_limbs/digits/tail_de | 1.00027879 |
| 55 | MP0002876_abnormal_thyroid_physiology | 0.97757494 |
| 56 | MP0003632_abnormal_nervous_system | 0.96874284 |
| 57 | MP0002148_abnormal_hypersensitivity_rea | 0.95731936 |
| 58 | MP0009764_decreased_sensitivity_to | 0.95099551 |
| 59 | MP0002111_abnormal_tail_morphology | 0.92975846 |
| 60 | MP0000751_myopathy | 0.92252674 |
| 61 | MP0003119_abnormal_digestive_system | 0.87810347 |
| 62 | MP0000639_abnormal_adrenal_gland | 0.87211155 |
| 63 | MP0000538_abnormal_urinary_bladder | 0.86030999 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.85574646 |
| 65 | MP0004134_abnormal_chest_morphology | 0.85360706 |
| 66 | MP0005332_abnormal_amino_acid | 0.84600036 |
| 67 | MP0004133_heterotaxia | 0.83310426 |
| 68 | MP0009745_abnormal_behavioral_response | 0.82848062 |
| 69 | MP0002751_abnormal_autonomic_nervous | 0.80616116 |
| 70 | MP0003122_maternal_imprinting | 0.79563572 |
| 71 | MP0001486_abnormal_startle_reflex | 0.78765493 |
| 72 | MP0005220_abnormal_exocrine_pancreas | 0.78282866 |
| 73 | MP0002139_abnormal_hepatobiliary_system | 0.78206456 |
| 74 | MP0000470_abnormal_stomach_morphology | 0.78169323 |
| 75 | MP0001984_abnormal_olfaction | 0.77958304 |
| 76 | MP0003698_abnormal_male_reproductive | 0.76798664 |
| 77 | MP0004742_abnormal_vestibular_system | 0.76094094 |
| 78 | MP0000049_abnormal_middle_ear | 0.75231091 |
| 79 | MP0005360_urolithiasis | 0.74981503 |
| 80 | MP0003329_amyloid_beta_deposits | 0.74292366 |
| 81 | MP0002752_abnormal_somatic_nervous | 0.71363993 |
| 82 | MP0002152_abnormal_brain_morphology | 0.71272741 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.69889425 |
| 84 | MP0002938_white_spotting | 0.69144833 |
| 85 | MP0000647_abnormal_sebaceous_gland | 0.67569452 |
| 86 | MP0002063_abnormal_learning/memory/cond | 0.66796368 |
| 87 | MP0000685_abnormal_immune_system | 0.65232217 |
| 88 | MP0004085_abnormal_heartbeat | 0.64411959 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.63025137 |
| 90 | MP0002064_seizures | 0.60703601 |
| 91 | MP0002882_abnormal_neuron_morphology | 0.59480146 |
| 92 | MP0004147_increased_porphyrin_level | 0.59342236 |
| 93 | MP0004885_abnormal_endolymph | 0.57827264 |
| 94 | MP0002233_abnormal_nose_morphology | 0.57609120 |
| 95 | MP0002069_abnormal_eating/drinking_beha | 0.56443492 |
| 96 | MP0002109_abnormal_limb_morphology | 0.55545955 |
| 97 | MP0001929_abnormal_gametogenesis | 0.55514160 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.55187638 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.54982152 |
| 100 | MP0002115_abnormal_skeleton_extremities | 0.53999511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperventilation (HP:0002883) | 7.02842150 |
| 2 | Congenital stationary night blindness (HP:0007642) | 6.94779042 |
| 3 | Limb dystonia (HP:0002451) | 6.32340266 |
| 4 | Oligodactyly (hands) (HP:0001180) | 4.63483119 |
| 5 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.63139491 |
| 6 | Renal cortical cysts (HP:0000803) | 4.42151359 |
| 7 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 4.13664996 |
| 8 | Global brain atrophy (HP:0002283) | 4.02651146 |
| 9 | 3-Methylglutaconic aciduria (HP:0003535) | 3.98067036 |
| 10 | Microvesicular hepatic steatosis (HP:0001414) | 3.81668514 |
| 11 | Concave nail (HP:0001598) | 3.77531922 |
| 12 | Abnormality of the renal cortex (HP:0011035) | 3.76521198 |
| 13 | Gait imbalance (HP:0002141) | 3.63005812 |
| 14 | Growth hormone deficiency (HP:0000824) | 3.60562237 |
| 15 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.59296341 |
| 16 | Fibular hypoplasia (HP:0003038) | 3.46838528 |
| 17 | Tubular atrophy (HP:0000092) | 3.45593036 |
| 18 | Protruding tongue (HP:0010808) | 3.43161608 |
| 19 | Methylmalonic aciduria (HP:0012120) | 3.32385035 |
| 20 | Abnormality of the 4th metacarpal (HP:0010012) | 3.29925765 |
| 21 | Brushfield spots (HP:0001088) | 3.26953876 |
| 22 | Congenital primary aphakia (HP:0007707) | 3.26122898 |
| 23 | Medial flaring of the eyebrow (HP:0010747) | 3.15627832 |
| 24 | Turricephaly (HP:0000262) | 3.03264921 |
| 25 | Oligodactyly (HP:0012165) | 3.00529642 |
| 26 | Pancreatic cysts (HP:0001737) | 2.98566116 |
| 27 | Nephrogenic diabetes insipidus (HP:0009806) | 2.97071020 |
| 28 | Hyperalaninemia (HP:0003348) | 2.89988077 |
| 29 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89988077 |
| 30 | Abnormality of alanine metabolism (HP:0010916) | 2.89988077 |
| 31 | Spastic tetraparesis (HP:0001285) | 2.88545935 |
| 32 | Widely patent fontanelles and sutures (HP:0004492) | 2.86244891 |
| 33 | Congenital, generalized hypertrichosis (HP:0004540) | 2.84264096 |
| 34 | Prolonged neonatal jaundice (HP:0006579) | 2.81690861 |
| 35 | Cheilitis (HP:0100825) | 2.81414123 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 2.80829867 |
| 37 | Nephronophthisis (HP:0000090) | 2.76823519 |
| 38 | Bile duct proliferation (HP:0001408) | 2.73665429 |
| 39 | Abnormal biliary tract physiology (HP:0012439) | 2.73665429 |
| 40 | Testicular atrophy (HP:0000029) | 2.73307392 |
| 41 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.70413027 |
| 42 | Breech presentation (HP:0001623) | 2.67359883 |
| 43 | Long nose (HP:0003189) | 2.66786108 |
| 44 | Furrowed tongue (HP:0000221) | 2.63288247 |
| 45 | Abnormal number of erythroid precursors (HP:0012131) | 2.63257867 |
| 46 | Flat occiput (HP:0005469) | 2.62496465 |
| 47 | Bell-shaped thorax (HP:0001591) | 2.62456406 |
| 48 | Adrenal hypoplasia (HP:0000835) | 2.60750397 |
| 49 | Progressive inability to walk (HP:0002505) | 2.57941277 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.57642111 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57642111 |
| 52 | Intellectual disability, progressive (HP:0006887) | 2.55085991 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.54891841 |
| 54 | Chorioretinal atrophy (HP:0000533) | 2.47551892 |
| 55 | Partial agenesis of the corpus callosum (HP:0001338) | 2.44764477 |
| 56 | Pancreatic fibrosis (HP:0100732) | 2.42827926 |
| 57 | Enlarged kidneys (HP:0000105) | 2.41988544 |
| 58 | Attenuation of retinal blood vessels (HP:0007843) | 2.37890816 |
| 59 | Molar tooth sign on MRI (HP:0002419) | 2.35684850 |
| 60 | Abnormality of midbrain morphology (HP:0002418) | 2.35684850 |
| 61 | Dyschromatopsia (HP:0007641) | 2.34180836 |
| 62 | Poor coordination (HP:0002370) | 2.34020504 |
| 63 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.33734574 |
| 64 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.29291730 |
| 65 | Vaginal atresia (HP:0000148) | 2.24738749 |
| 66 | True hermaphroditism (HP:0010459) | 2.20618231 |
| 67 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 2.18961228 |
| 68 | Retinal atrophy (HP:0001105) | 2.18856271 |
| 69 | Genital tract atresia (HP:0001827) | 2.17953401 |
| 70 | Abnormality of the renal medulla (HP:0100957) | 2.16211529 |
| 71 | Intellectual disability, severe (HP:0010864) | 2.15540170 |
| 72 | Macroglossia (HP:0000158) | 2.14976763 |
| 73 | Clitoromegaly (HP:0000057) | 2.14050967 |
| 74 | Congenital sensorineural hearing impairment (HP:0008527) | 2.13044503 |
| 75 | Inability to walk (HP:0002540) | 2.12261553 |
| 76 | Anophthalmia (HP:0000528) | 2.12189280 |
| 77 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.10673300 |
| 78 | Unsteady gait (HP:0002317) | 2.07973644 |
| 79 | Prominent supraorbital ridges (HP:0000336) | 2.04114946 |
| 80 | Chronic hepatic failure (HP:0100626) | 2.00120523 |
| 81 | Left ventricular hypertrophy (HP:0001712) | 1.96374186 |
| 82 | Decreased central vision (HP:0007663) | 1.95774742 |
| 83 | Postaxial foot polydactyly (HP:0001830) | 1.95465097 |
| 84 | Anencephaly (HP:0002323) | 1.94996472 |
| 85 | Mesangial abnormality (HP:0001966) | 1.93832722 |
| 86 | Clumsiness (HP:0002312) | 1.92693927 |
| 87 | Rib fusion (HP:0000902) | 1.91939557 |
| 88 | Amelogenesis imperfecta (HP:0000705) | 1.90014078 |
| 89 | Large for gestational age (HP:0001520) | 1.87407014 |
| 90 | Tachypnea (HP:0002789) | 1.84481954 |
| 91 | Limb hypertonia (HP:0002509) | 1.83776977 |
| 92 | Hypokinesia (HP:0002375) | 1.81725697 |
| 93 | Posterior embryotoxon (HP:0000627) | 1.81190481 |
| 94 | Metatarsus adductus (HP:0001840) | 1.80795844 |
| 95 | Acute lymphatic leukemia (HP:0006721) | 1.79759928 |
| 96 | Prolonged QT interval (HP:0001657) | 1.79090426 |
| 97 | Progressive microcephaly (HP:0000253) | 1.76763453 |
| 98 | Decreased testicular size (HP:0008734) | 1.76450647 |
| 99 | Febrile seizures (HP:0002373) | 1.76169722 |
| 100 | Hyperglycinuria (HP:0003108) | 1.75452525 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 6.07166122 |
| 2 | MAPKAPK5 | 3.53055522 |
| 3 | NME1 | 3.44693206 |
| 4 | MAPK13 | 3.34221379 |
| 5 | NEK9 | 2.96611350 |
| 6 | PKN1 | 2.89314310 |
| 7 | MAP3K4 | 2.87106506 |
| 8 | PIK3CG | 2.58866313 |
| 9 | NTRK2 | 2.50125350 |
| 10 | WNK3 | 2.41770322 |
| 11 | PLK4 | 2.41050643 |
| 12 | GRK1 | 2.32011260 |
| 13 | ZAK | 2.24033249 |
| 14 | ACVR1B | 2.02057440 |
| 15 | OXSR1 | 1.77902618 |
| 16 | ADRBK2 | 1.74981073 |
| 17 | UHMK1 | 1.62240359 |
| 18 | CAMK2B | 1.62211667 |
| 19 | STK39 | 1.55372907 |
| 20 | MARK1 | 1.53626737 |
| 21 | KDR | 1.53093761 |
| 22 | TRPM7 | 1.49714393 |
| 23 | NEK2 | 1.47706601 |
| 24 | MAPKAPK3 | 1.40024719 |
| 25 | ADRBK1 | 1.39457044 |
| 26 | CHEK2 | 1.28158863 |
| 27 | FRK | 1.25513451 |
| 28 | CSNK1G2 | 1.21287300 |
| 29 | MKNK2 | 1.19492094 |
| 30 | CSNK1G3 | 1.17329658 |
| 31 | BMPR1B | 1.14034818 |
| 32 | BCKDK | 1.11257857 |
| 33 | CAMK2A | 1.06382297 |
| 34 | MET | 1.03115848 |
| 35 | CAMK4 | 1.00894112 |
| 36 | DYRK3 | 0.99648601 |
| 37 | PLK2 | 0.97745782 |
| 38 | NEK1 | 0.97328735 |
| 39 | RPS6KA5 | 0.97312719 |
| 40 | CDK15 | 0.93379135 |
| 41 | MAPK4 | 0.92954865 |
| 42 | CAMK2D | 0.91753380 |
| 43 | DYRK2 | 0.90529656 |
| 44 | CDK18 | 0.87700781 |
| 45 | GRK7 | 0.87077231 |
| 46 | CDK8 | 0.85878855 |
| 47 | CSNK1G1 | 0.82679117 |
| 48 | PRKCQ | 0.82593921 |
| 49 | STK38L | 0.82533589 |
| 50 | CDK11A | 0.81547100 |
| 51 | CAMK2G | 0.79609346 |
| 52 | CDK14 | 0.76889503 |
| 53 | PRKCG | 0.75548976 |
| 54 | WNK4 | 0.72866511 |
| 55 | PHKG2 | 0.69914065 |
| 56 | PHKG1 | 0.69914065 |
| 57 | STK11 | 0.68001484 |
| 58 | MATK | 0.65059620 |
| 59 | MAP2K1 | 0.64106214 |
| 60 | PRKCZ | 0.63411717 |
| 61 | DYRK1A | 0.60689508 |
| 62 | PRKCI | 0.58742185 |
| 63 | DYRK1B | 0.58608991 |
| 64 | MAP2K7 | 0.57761308 |
| 65 | MAP3K7 | 0.56033144 |
| 66 | MAP2K2 | 0.55126186 |
| 67 | DDR2 | 0.53790090 |
| 68 | EIF2AK2 | 0.53472720 |
| 69 | SYK | 0.52228875 |
| 70 | CDC42BPA | 0.50924113 |
| 71 | KIT | 0.50044458 |
| 72 | INSRR | 0.48996374 |
| 73 | OBSCN | 0.47641508 |
| 74 | PLK1 | 0.47279475 |
| 75 | FGR | 0.46775433 |
| 76 | CDK19 | 0.46685550 |
| 77 | DAPK2 | 0.46583453 |
| 78 | STK24 | 0.45673307 |
| 79 | PRKACA | 0.43298301 |
| 80 | ABL2 | 0.43114338 |
| 81 | PTK2B | 0.42542198 |
| 82 | IRAK4 | 0.42428610 |
| 83 | GRK5 | 0.42116678 |
| 84 | CSNK1A1 | 0.42072720 |
| 85 | MKNK1 | 0.41363091 |
| 86 | TTK | 0.41208991 |
| 87 | PRKCB | 0.40297282 |
| 88 | TGFBR1 | 0.39758450 |
| 89 | MAPK12 | 0.39024574 |
| 90 | CSF1R | 0.38814624 |
| 91 | CSNK1A1L | 0.38122579 |
| 92 | TLK1 | 0.35024223 |
| 93 | PRKG1 | 0.34737192 |
| 94 | PRKAA2 | 0.33344501 |
| 95 | MAPK3 | 0.33313179 |
| 96 | CSNK1D | 0.32681554 |
| 97 | CDK5 | 0.31700420 |
| 98 | PRKCD | 0.31254068 |
| 99 | PRKCA | 0.30727973 |
| 100 | PRKACB | 0.30084249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 7.68791274 |
| 2 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 6.89127561 |
| 3 | Ether lipid metabolism_Homo sapiens_hsa00565 | 4.71814651 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 3.48026534 |
| 5 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 3.08843264 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.62888236 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.36245336 |
| 8 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 2.29423371 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14990787 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 1.96775144 |
| 11 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.95136820 |
| 12 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.86828596 |
| 13 | Basal transcription factors_Homo sapiens_hsa03022 | 1.81961418 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.62788503 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59342442 |
| 16 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.48148186 |
| 17 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39137751 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.23714491 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21059395 |
| 20 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16365051 |
| 21 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12107370 |
| 22 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08385148 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.07089368 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02276206 |
| 25 | Cocaine addiction_Homo sapiens_hsa05030 | 0.96318520 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95422386 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 0.94703452 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.93816405 |
| 29 | Sulfur relay system_Homo sapiens_hsa04122 | 0.88133007 |
| 30 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86902466 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 0.84549494 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84161893 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.79931014 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.76286589 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72961909 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72772535 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65629623 |
| 38 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65628069 |
| 39 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.63741122 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.61408239 |
| 41 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.61186963 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57383355 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57305358 |
| 44 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57148793 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56120875 |
| 46 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56057943 |
| 47 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.55265244 |
| 48 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55044634 |
| 49 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53643141 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53348011 |
| 51 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.49433628 |
| 52 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49246260 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.48896274 |
| 54 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47906362 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.47378493 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46207756 |
| 57 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45275837 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45239149 |
| 59 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.44334663 |
| 60 | Homologous recombination_Homo sapiens_hsa03440 | 0.43400865 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42506484 |
| 62 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42195017 |
| 63 | Peroxisome_Homo sapiens_hsa04146 | 0.41586834 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40990379 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39633956 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.39201780 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.37800807 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.35618122 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35441260 |
| 70 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.34594751 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.33700387 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.32232359 |
| 73 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.30669606 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.30058278 |
| 75 | Salivary secretion_Homo sapiens_hsa04970 | 0.28027928 |
| 76 | Morphine addiction_Homo sapiens_hsa05032 | 0.27292329 |
| 77 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27284185 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.26959946 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.24759698 |
| 80 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.24622978 |
| 81 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24397331 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23489165 |
| 83 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.23480078 |
| 84 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.20807923 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.18289576 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.17864677 |
| 87 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17707354 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.16564853 |
| 89 | Circadian rhythm_Homo sapiens_hsa04710 | 0.15963725 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.15924160 |
| 91 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.13531961 |
| 92 | Axon guidance_Homo sapiens_hsa04360 | 0.12958307 |
| 93 | Protein export_Homo sapiens_hsa03060 | 0.12677028 |
| 94 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.12667891 |
| 95 | RNA polymerase_Homo sapiens_hsa03020 | 0.12638954 |
| 96 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.12630819 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.12174496 |
| 98 | Purine metabolism_Homo sapiens_hsa00230 | 0.11195887 |
| 99 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.11157483 |
| 100 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.11015453 |

